ANGLE plc announced the appointment of James M. Reuben, PhD, MBA, as a Scientific Advisor to the company with immediate effect. For the past 30 years, Dr. Reuben has been a member of the American Association for Cancer Research (AACR), and the American Society of Clinical Oncology (ASCO). He has also been a member of the American Society of Hematology since January, 2000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15 GBX | 0.00% | -20.00% | +27.66% |
05/06 | EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows | AN |
05/06 | Angle plc to Raise GBP10.6 Million via Share Placing, Subscription, Open Offer | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.66% | 60.87M | |
-26.77% | 16.48B | |
-43.46% | 2.79B | |
+22.46% | 1.94B | |
-12.32% | 1.46B | |
+31.49% | 1.33B | |
-16.15% | 966M | |
+1.33% | 791M | |
-31.07% | 788M | |
-25.95% | 620M |
- Stock Market
- Equities
- AGL Stock
- News ANGLE plc
- ANGLE plc Appoints James M. Reuben as Scientific Advisor